ICU Medical, Inc. (ICUI)
NASDAQ: ICUI · Real-Time Price · USD
156.82
+3.62 (2.36%)
Dec 20, 2024, 4:00 PM EST - Market closed
ICU Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 2,340 | 2,259 | 2,280 | 1,316 | 1,271 | 1,266 | Upgrade
|
| Revenue | 2,340 | 2,259 | 2,280 | 1,316 | 1,271 | 1,266 | Upgrade
|
| Revenue Growth (YoY) | 4.04% | -0.92% | 73.21% | 3.56% | 0.38% | -9.56% | Upgrade
|
| Cost of Revenue | 1,571 | 1,519 | 1,582 | 824.82 | 809.51 | 794.34 | Upgrade
|
| Gross Profit | 769.11 | 739.87 | 697.76 | 491.49 | 461.5 | 471.86 | Upgrade
|
| Selling, General & Admin | 634.53 | 606.69 | 608.35 | 302.58 | 283.95 | 276.98 | Upgrade
|
| Research & Development | 88.67 | 85.34 | 92.98 | 47.5 | 42.95 | 48.61 | Upgrade
|
| Operating Expenses | 723.2 | 692.04 | 701.33 | 350.08 | 326.9 | 325.59 | Upgrade
|
| Operating Income | 45.91 | 47.84 | -3.57 | 141.41 | 134.6 | 146.27 | Upgrade
|
| Interest Expense | -107.06 | -102.73 | -70.81 | -0.86 | -1.75 | -0.55 | Upgrade
|
| Interest & Investment Income | 10.36 | 7.51 | 4.43 | 2.84 | 3.68 | 6.8 | Upgrade
|
| Currency Exchange Gain (Loss) | -7.77 | -5.92 | -5.78 | -1.02 | - | 0.7 | Upgrade
|
| Other Non Operating Income (Expenses) | -2.92 | -2.43 | 3.2 | 0.63 | 2.81 | 0.4 | Upgrade
|
| EBT Excluding Unusual Items | -61.49 | -55.74 | -72.53 | 143 | 139.33 | 153.62 | Upgrade
|
| Merger & Restructuring Charges | -60.8 | -41.26 | -71.42 | -18.04 | -28.41 | -80.57 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.8 | -0.15 | -2.55 | -1.65 | 1.77 | - | Upgrade
|
| Other Unusual Items | 7.98 | 16.25 | 32.09 | -0.13 | -15.2 | 41.66 | Upgrade
|
| Pretax Income | -110.91 | -78.3 | -114.41 | 123.19 | 97.49 | 114.71 | Upgrade
|
| Income Tax Expense | 0.1 | -48.64 | -40.12 | 20.05 | 10.62 | 13.67 | Upgrade
|
| Net Income | -111.01 | -29.66 | -74.29 | 103.14 | 86.87 | 101.04 | Upgrade
|
| Net Income to Common | -111.01 | -29.66 | -74.29 | 103.14 | 86.87 | 101.04 | Upgrade
|
| Net Income Growth | - | - | - | 18.72% | -14.02% | 250.90% | Upgrade
|
| Shares Outstanding (Basic) | 24 | 24 | 24 | 21 | 21 | 21 | Upgrade
|
| Shares Outstanding (Diluted) | 24 | 24 | 24 | 22 | 22 | 22 | Upgrade
|
| Shares Change (YoY) | 1.02% | 0.93% | 9.58% | 0.88% | 0.21% | -0.26% | Upgrade
|
| EPS (Basic) | -4.57 | -1.23 | -3.11 | 4.86 | 4.16 | 4.90 | Upgrade
|
| EPS (Diluted) | -4.57 | -1.23 | -3.11 | 4.74 | 4.02 | 4.69 | Upgrade
|
| EPS Growth | - | - | - | 17.91% | -14.29% | 252.63% | Upgrade
|
| Free Cash Flow | 169.88 | 82.31 | -152.44 | 199 | 130.75 | 4.61 | Upgrade
|
| Free Cash Flow Per Share | 6.99 | 3.42 | -6.39 | 9.14 | 6.06 | 0.21 | Upgrade
|
| Gross Margin | 32.87% | 32.75% | 30.60% | 37.34% | 36.31% | 37.27% | Upgrade
|
| Operating Margin | 1.96% | 2.12% | -0.16% | 10.74% | 10.59% | 11.55% | Upgrade
|
| Profit Margin | -4.74% | -1.31% | -3.26% | 7.84% | 6.83% | 7.98% | Upgrade
|
| Free Cash Flow Margin | 7.26% | 3.64% | -6.69% | 15.12% | 10.29% | 0.36% | Upgrade
|
| EBITDA | 269.59 | 276.61 | 231.58 | 231.11 | 220.23 | 223.19 | Upgrade
|
| EBITDA Margin | 11.52% | 12.24% | 10.16% | 17.56% | 17.33% | 17.63% | Upgrade
|
| D&A For EBITDA | 223.68 | 228.77 | 235.15 | 89.7 | 85.63 | 76.92 | Upgrade
|
| EBIT | 45.91 | 47.84 | -3.57 | 141.41 | 134.6 | 146.27 | Upgrade
|
| EBIT Margin | 1.96% | 2.12% | -0.16% | 10.74% | 10.59% | 11.55% | Upgrade
|
| Effective Tax Rate | - | - | - | 16.28% | 10.90% | 11.92% | Upgrade
|
| Advertising Expenses | - | - | - | - | - | 0.1 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.